Roche Holding AG-Genusschein
13F holders, Q3 2024 (September 30)2holders −1
0new positions
1sold out
$320.79avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Roche Holding AG-Genusschein in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Aristotle Capital Management, LLC ($77.8M) and Boston Common Asset Management, LLC ($16.5M).
- Company
- Roche Holding AG-Genusschein
- CUSIP
- H69293217
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3.5M |
All 13F filers, Q2 2024 → Q3 2024: 18,097 shares sold, net −18,097 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.14% | Reduce -0.2% | 242,465 | $77.8M |
| Boston Common Asset Management, LLC | 0.43% | Reduce -9.1% | 51,317 | $16.5M |
"% of holder's portfolio" is ROCHE HOLDING AG-GENUSSCHEIN's weight in each manager's 13F, not the share of Roche Holding AG-Genusschein the manager owns.